Targeting regulatory T cells with HFB101110, a novel anti-human CCR8 antibody for the treatment of solid tumors April 18, 2022 Publications Twitter LinkedIn Presenters: Roshan Kumar, Julie Prigent, Hombline Poullain, Ayrin Kök, Carine George, Sami Ellouze, Yun-Yueh Lu, Rebecca Silver, Clarisse Monchecourt, Ross Fulton, Qian Zhang, Nicola Beltraminelli, Bernhard Moser, Francisco Adrian, Liang Schweizer Twitter LinkedIn Posted April 18, 2022 under Publications